| 1 |
29247830 | Phase 2 Study of the HSP-90 Inhibitor AUY922 in Previously Treated and Molecularly Defined Patients with Advanced Non-Small Cell Lung Cancer. | 2018 Apr |
1 |
| 2 |
30154228 | EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas. | 2018 Dec 15 |
4 |
| 3 |
30351341 | Activity of the Hsp90 inhibitor luminespib among non-small-cell lung cancers harboring EGFR exon 20 insertions. | 2018 Oct 1 |
2 |
| 4 |
28315949 | 89Zr-Onartuzumab PET imaging of c-MET receptor dynamics. | 2017 Aug |
2 |
| 5 |
25780909 | AUY922 effectively overcomes MET- and AXL-mediated resistance to EGFR-TKI in lung cancer cells. | 2015 |
1 |
| 6 |
25870087 | Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. | 2015 May 20 |
1 |